These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24934660)

  • 1. A novel model for Ki67 assessment in breast cancer.
    Romero Q; Bendahl PO; Fernö M; Grabau D; Borgquist S
    Diagn Pathol; 2014 Jun; 9():118. PubMed ID: 24934660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of tissue sampling on accuracy of Ki67 immunohistochemistry evaluation in breast cancer.
    Besusparis J; Plancoulaine B; Rasmusson A; Augulis R; Green AR; Ellis IO; Laurinaviciene A; Herlin P; Laurinavicius A
    Diagn Pathol; 2016 Aug; 11(1):82. PubMed ID: 27576949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interlaboratory variability of Ki67 staining in breast cancer.
    Focke CM; Bürger H; van Diest PJ; Finsterbusch K; Gläser D; Korsching E; Decker T;
    Eur J Cancer; 2017 Oct; 84():219-227. PubMed ID: 28829990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual assessment of Ki67 using a 5-grade scale (Eye-5) is easy and practical to classify breast cancer subtypes with high reproducibility.
    Hida AI; Bando K; Sugita A; Maeda T; Ueda N; Matsukage S; Nakanishi M; Kito K; Miyazaki T; Ohtsuki Y; Oshiro Y; Inoue H; Kawaguchi H; Yamashita N; Aogi K; Moriya T
    J Clin Pathol; 2015 May; 68(5):356-61. PubMed ID: 25673730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue.
    Laurinavicius A; Plancoulaine B; Laurinaviciene A; Herlin P; Meskauskas R; Baltrusaityte I; Besusparis J; Dasevicius D; Elie N; Iqbal Y; Bor C
    Breast Cancer Res; 2014; 16(2):R35. PubMed ID: 24708745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The region-of-interest size impacts on Ki67 quantification by computer-assisted image analysis in breast cancer.
    Christgen M; von Ahsen S; Christgen H; Länger F; Kreipe H
    Hum Pathol; 2015 Sep; 46(9):1341-9. PubMed ID: 26206765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies.
    Romero Q; Bendahl PO; Klintman M; Loman N; Ingvar C; Rydén L; Rose C; Grabau D; Borgquist S
    BMC Cancer; 2011 Aug; 11():341. PubMed ID: 21819622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer stromal elastosis is associated with mammography screening detection, low Ki67 expression and favourable prognosis in a population-based study.
    Chen Y; Klingen TA; Wik E; Aas H; Vigeland E; Liestøl K; Garred Ø; Mæhlen J; Akslen LA; Lømo J
    Diagn Pathol; 2014 Dec; 9():230. PubMed ID: 25522915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential immunohistochemistry and virtual image reconstruction using a single slide for quantitative KI67 measurement in breast cancer.
    Serna G; Simonetti S; Fasani R; Pagliuca F; Guardia X; Gallego P; Jimenez J; Peg V; Saura C; Eppenberger-Castori S; Ramon Y Cajal S; Terracciano L; Nuciforo P
    Breast; 2020 Oct; 53():102-110. PubMed ID: 32707454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The additional value of ONEST (Observers Needed to Evaluate Subjective Tests) in assessing reproducibility of oestrogen receptor, progesterone receptor, and Ki67 classification in breast cancer.
    Cserni B; Bori R; Csörgő E; Oláh-Németh O; Pancsa T; Sejben A; Sejben I; Vörös A; Zombori T; Nyári T; Cserni G
    Virchows Arch; 2021 Dec; 479(6):1101-1109. PubMed ID: 34415429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An international Ki67 reproducibility study.
    Polley MY; Leung SC; McShane LM; Gao D; Hugh JC; Mastropasqua MG; Viale G; Zabaglo LA; Penault-Llorca F; Bartlett JM; Gown AM; Symmans WF; Piper T; Mehl E; Enos RA; Hayes DF; Dowsett M; Nielsen TO;
    J Natl Cancer Inst; 2013 Dec; 105(24):1897-906. PubMed ID: 24203987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki 67 assessment in breast cancer in an Egyptian population: a comparative study between manual assessment on optical microscopy and digital quantitative assessment.
    Ayad E; Soliman A; Anis SE; Salem AB; Hu P; Dong Y
    Diagn Pathol; 2018 Aug; 13(1):63. PubMed ID: 30153851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation assessment in breast carcinomas using digital image analysis based on virtual Ki67/cytokeratin double staining.
    Røge R; Riber-Hansen R; Nielsen S; Vyberg M
    Breast Cancer Res Treat; 2016 Jul; 158(1):11-19. PubMed ID: 27283833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment.
    Fasching PA; Heusinger K; Haeberle L; Niklos M; Hein A; Bayer CM; Rauh C; Schulz-Wendtland R; Bani MR; Schrauder M; Kahmann L; Lux MP; Strehl JD; Hartmann A; Dimmler A; Beckmann MW; Wachter DL
    BMC Cancer; 2011 Nov; 11():486. PubMed ID: 22081974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An interobserver reproducibility analysis of size-set semiautomatic counting for Ki67 assessment in breast cancer.
    Wang YX; Wang YY; Yang CG; Bu H; Yang WT; Wang L; Xu WM; Zhao XL; Zhao WX; Li L; Song SL; Yang JL
    Breast; 2020 Feb; 49():225-232. PubMed ID: 31911370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between Ki67 labeling index determined using image analysis software with virtual slide system and that determined visually in breast cancer.
    Maeda I; Abe K; Koizumi H; Nakajima C; Tajima S; Aoki H; Tsuchiya J; Tsuchiya S; Tsuchiya K; Shimo A; Tsugawa K; Ueno T; Tatsunami S; Takagi M
    Breast Cancer; 2016 Sep; 23(5):745-51. PubMed ID: 26271611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interobserver concordance in visual assessment of Ki67 immunohistochemistry in surgical excision specimens from patients with lymph node-negative breast cancer.
    Thomas S; Kabir M; Butcher BE; Chou S; Mahajan H; Farshid G; Balleine R; Pathmanathan N
    Breast Cancer Res Treat; 2021 Aug; 188(3):729-737. PubMed ID: 33751322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.
    Ignatiadis M; Azim HA; Desmedt C; Veys I; Larsimont D; Salgado R; Lyng MB; Viale G; Leyland-Jones B; Giobbie-Hurder A; Kammler R; Dell'Orto P; Rothé F; Laïos I; Ditzel HJ; Regan MM; Piccart M; Michiels S; Sotiriou C
    JAMA Oncol; 2016 Feb; 2(2):217-24. PubMed ID: 26633571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of Ki67 analysed by cytology or histology in primary breast cancer.
    Robertson S; Stålhammar G; Darai-Ramqvist E; Rantalainen M; Tobin NP; Bergh J; Hartman J
    J Clin Pathol; 2018 Sep; 71(9):787-794. PubMed ID: 29588372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods.
    Tang LH; Gonen M; Hedvat C; Modlin IM; Klimstra DS
    Am J Surg Pathol; 2012 Dec; 36(12):1761-70. PubMed ID: 23026928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.